Lisa Vandermeer

6PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersDeep learningMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 27, 2026
A Randomized Trial Evaluating Personalized Versus Guideline-Based Well Follow-Up Strategies for Patients with Early Breast Cancer: Feasibility Outcomes.

|Apr 14, 2026
Transfer Learning and Machine Learning for Training Five-Year Survival Prognostic Models in Early Breast Cancer: Development and Validation Study.

Lisa Pilgram, Kai Yang, Ana-Alicia Beltran-Bless

|Mar 07, 2025
Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study.

Samer El Kababji, Nicholas Mitsakakis, Elizabeth Jonker

|Mar 27, 2024
Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study.

Arif Ali Awan, Deanna Saunders, Gregory Pond

|Dec 22, 2023
Shorter Durations of Anti-HER2 Therapy for Patients with Early-Stage, HER2-Positive Breast Cancer: The Physician Perspective.

Michelle Bradbury, Marie-France Savard, Lisa Vandermeer

|Dec 22, 2022
Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) Program.

Bader Alshamsan, Brian Hutton, Michelle Liu

Pageof 1

Frequent Collaborators

5 joint publications

Mark Clemons

4 joint publications

Marie-France Savard

3 joint publications

Ana-Alicia Beltran-Bless

3 joint publications

Gregory R Pond